🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The goal of this clinical trial is to explore the effect of FDA-approved an...
Status
Terminated
Location
UNC Health
Start Date
2023-11-20
Trial ID
NCT06081283
EP0060 is a multicenter, open-label study to evaluate the safety and tolera...
Status
Completed
Location
Ep0060 003
Start Date
2017-05-30
Trial ID
NCT02710890
Treatments Being Tested
The purpose of the trial is to evaluate the safety of intravenous (iv) laco...
Status
Completed
Location
Multiple Locations
Start Date
2008-04
Trial ID
NCT00655551
Treatments Being Tested
The purpose of this study is to evaluate the safety of IV Lacosamide in chi...
Status
Completed
Location
Lebonheur Children's Hospital
Start Date
2010-04
Trial ID
NCT01981447
Treatments Being Tested
To evaluate the safety of IV Lacosamide in children with partial-onset epil...
Status
Completed
Location
LeBonheur Children's Medical Center
Start Date
2010-03
Trial ID
NCT00832884
Treatments Being Tested
This a phase 2 study comparing the efficacy of intravenous (IV) lacosamide ...
Status
Completed
Location
Huntington Memorial Hospital
Start Date
2012-05
Trial ID
NCT01458522
This prospective observational study evaluates the effectiveness and safety...
Status
Recruiting
Location
Hospital de Bellvitge
Start Date
2025-04-21
Trial ID
NCT06851910
Treatments Being Tested
This study will be conducted to compare the pharmacokinetics of Lacosamide ...
Status
Completed
Location
001
Start Date
2013-11
Trial ID
NCT01986608
Treatments Being Tested
The purpose of this study is to assess the bioequivalence of a 200 mg singl...
Status
Completed
Location
Sp1043 001
Start Date
2017-06-08
Trial ID
NCT03204474
Treatments Being Tested
Lacosamide is a new antiepileptic drug (AED) marketed as Vimpat with three ...
Status
Completed
Location
Universitätsklinikum Schleswig-Holstein, Campus Kiel, Klinik für Neurologie
Start Date
2011-06
Trial ID
NCT01620840
Treatments Being Tested